Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

oxaliplatin

  • You have access
    A Randomised Controlled Phase II Trial of the Combination of XELOX with Thalidomide for the First-line Treatment of Metastatic Colorectal Cancer
    Jing Lv, Ning Liu, Ke-wei Liu, Ai-ping Ding, Hao Wang and Wen-sheng Qiu
    Cancer Biology & Medicine June 2012, 9 (2) 111-114; DOI: https://doi.org/10.3969/j.issn.2095-3941.2012.02.005
  • You have access
    Selective Internal Iliac Artery Oxaliplatin Infusion: Another Facultative Treatment to Unremitting Hematuria in Stage T4 Bladder Carcinoma
    Hai-peng YU, Zhi GUO, Wen-ge XING, Xiu-ying GUO, Fang LIU and Hong NI
    Clinical Oncology and Cancer Research February 2010, 7 (1) 55-59; DOI: https://doi.org/10.1007/s11805-010-0055-5
  • You have access
    Polymorphisms of ERCC1, XPD, XRCC1 and XPG Predict Clinical Outcome in Advanced Gastric Cancer Patients Receiving Oxaliplatin-Based Chemotherapy in Chinese Population
    Jian Jiang, Jun Liang, Ruyong Yao, Qingfang Li, Shanai Song and Yingying Sun
    Clinical Oncology and Cancer Research October 2009, 6 (5) 328-336; DOI: https://doi.org/10.1007/s11805-009-0328-z
  • You have access
    Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer
    Yuanjue Sun, Hui Zhao, Yaowu Guo, Feng Lin, Lina Tang and Yang Yao
    Clinical Oncology and Cancer Research April 2009, 6 (2) 117-123; DOI: https://doi.org/10.1007/s11805-009-0117-8
  • You have access
    Treatment of Advanced Gastric Carcinoma Patients with Calcium Folinate, a 5-Fluorouracil Bolus and Continous Infusion with 5-Fluorouracil Combined with Oxaliplatin
    Qilian Liang, Saihong Chen, Dachao Pan, Jierong Xie, Liangzhen Cai and Shujun Li
    Chinese Journal of Clinical Oncology August 2008, 5 (4) 273-276; DOI: https://doi.org/10.1007/s11805-008-0273-2
  • You have access
    Oxaliplatin, Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recurrent Colorectal Cancer Patients
    Bing Han, Ruihua Xu, Yanxia Shi, Huiyan Luo, Xiaojuan Xiang, Yuhong Li, Li Zhang, Tongyu Lin and Youjian He
    Chinese Journal of Clinical Oncology December 2007, 4 (6) 397-400; DOI: https://doi.org/10.1007/s11805-007-0397-9
  • You have access
    Clinical Research on Use of Oxaliplatin in Combination with HCPT, LV and 5FU in a Regimen for Advanced Gastric Cancer
    Guoqing Hu, Qiang Fu, Maolin Jin, Jie Li, Liangxi Pan, Yuxian Bai, Huaijin Wang, Jianwei Zhang and Ding Yu
    Chinese Journal of Clinical Oncology October 2004, 1 (5) 336-341;

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire